يعرض 1 - 20 نتائج من 31,700 نتيجة بحث عن '(( _ large decrease ) OR ((( a ((non decrease) OR (a decrease)) ) OR ( _ patients decrease ))))', وقت الاستعلام: 0.80s تنقيح النتائج
  1. 1
  2. 2

    Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. حسب Mieke L. M. Bentvelzen (21594442)

    منشور في 2025
    "…<p><b>(A)</b> Manhattan plot of minJSW decrease at 24 months. …"
  3. 3

    Baseline patient characteristics. حسب Oscar F. C. van den Bosch (22184246)

    منشور في 2025
    "…In contrast, s-ketamine largely preserved respiratory variability, suggesting it may be a safer alternative for sedation in patients with impaired spontaneous breathing. …"
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

    The capture efficiency of BioMagnetic solutions FerroSelect in PBS/1% BSA and whole blood showed a decrease in capture efficiency when moving to whole blood. حسب Peng Liu (120506)

    منشور في 2025
    "…<p>The capture efficiency of BioMagnetic solutions FerroSelect in PBS/1% BSA and whole blood showed a decrease in capture efficiency when moving to whole blood.…"
  9. 9
  10. 10

    Table1_Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease.docx حسب Jiahong Yi (14481735)

    منشور في 2024
    "…LTL might be a useful biomarker for prognosis among patients with ALD. …"
  11. 11
  12. 12
  13. 13

    Table 1_Effect of decreased suspended sediment content on chlorophyll-a in Dongting Lake, China.docx حسب Le Zhang (88249)

    منشور في 2025
    "…<p>Global damming of rivers strongly impacts the transport and characteristic of sediment, resulting in a significant reduction in the suspended sediment content (SSC) flowing into the downstream. …"
  14. 14

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc حسب Lei Wang (6656)

    منشور في 2025
    "…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …"
  15. 15

    The introduction of mutualisms into assembled communities increases their connectance and complexity while decreasing their richness. حسب Gui Araujo (22170819)

    منشور في 2025
    "…When they stop being introduced in further assembly events (i.e. introduced species do not carry any mutualistic interactions), their proportion slowly decreases with successive invasions. (B) Even though higher proportions of mutualism promote higher richness, introducing this type of interaction into already assembled large communities promotes a sudden drop in richness, while stopping mutualism promotes a slight boost in richness increase. …"
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20